Difference between revisions of "Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5 (Q9574)"

@@ Property / Publication Date @@
+Timestamp +2017-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2017-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2017 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Cancer Sci.
@@ Property / Published In Name String: Cancer Sci. / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 108 / rank @@
+Normal rank
@@ Property / title @@
+Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English)
+Normal rank
@@ Property / Page(s) @@
+-580
@@ Property / Page(s): 574-580 / rank @@
+Normal rank
@@ Property / Fourth Author string @@
+Yoshimura A
@@ Property / Fourth Author string: Yoshimura A / rank @@
+Normal rank

Latest revision as of 13:49, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8